
# Title 21 - Food and Drugs
## Chapter II - Drug Enforcement Administration, Department of Justice
### PART 1305 - ORDERS FOR SCHEDULE I AND II CONTROLLED SUBSTANCES
#### Subpart B - DEA Form 222
##### ยง 1305.20 Transition provisions allowing continued use of existing stocks of triplicate DEA Forms 222.
###### Preservation of triplicate DEA Forms 222.

(g)(1) The purchaser must retain Copy 3 of each executed triplicate DEA Form 222 and all copies of unaccepted or defective forms with each statement attached.

(2) The supplier must retain Copy 1 of each triplicate DEA Form 222 that it has filled.

(3) Triplicate DEA Forms 222 must be maintained separately from all other records of the registrant. Triplicate DEA Forms 222 are required to be kept available for inspection for a period of two years. If a purchaser has several registered locations, the purchaser must retain Copy 3 of the executed triplicate DEA Form 222 and any attached statements or other related documents (not including unexecuted triplicate DEA Forms 222, which may be kept elsewhere under paragraph (b)(5) of this section), at the registered location printed on the triplicate DEA Form 222.

(4) The supplier of thiafentanil, carfentanil, etorphine hydrochloride, and diprenorphine must maintain triplicate DEA Forms 222 for these substances separately from all other DEA triplicate Forms 222 and records required to be maintained by the registrant.
